The first Trillium Therapeutics trade was made in Q4 2017.
Since then Ken Griffin bought shares five more times and sold shares on seven occasions. The investor completely sold their stake between Q3 2021 and Q4 2021.
Avg closing price
Price range
Sold -799 Thousand shares
Q4 2021
Avg closing price
$17.82
Price range
$17.50
-
$18.44
Sold 80.8% shares (-3.37 Million shares)
Q3 2021
Avg closing price
$11.68
Price range
$5.86
-
$17.80
Increased shares by 18.6% (+655 Thousand shares)
Q2 2021
Avg closing price
$9.41
Price range
$7.48
-
$11.18
Sold 6.2% shares (-231 Thousand shares)
Q1 2021
Avg closing price
$12.37
Price range
$9.86
-
$15.51
Increased shares by 16.2% (+521 Thousand shares)
Q3 2020